Business UpdateJun 9, 2026, 09:01 AM
Alps Group's MyGenome Accredited for Whole Genome Sequencing
AI Summary
Alps Group Inc announced that its subsidiary, MyGenome Sdn. Bhd., has received MS ISO 15189:2022 accreditation for Whole Genome Sequencing (WGS). This internationally recognized clinical standard validates MyGenome's genomic data for accuracy, reproducibility, and reliability, positioning it among a select group of genomics laboratories in Southeast Asia. The accreditation expands Alps' addressable market to include government-linked healthcare programs, cross-border partnerships, and institutional clients, strengthening its position in Southeast Asian genomics.
Key Highlights
- Alps Group's subsidiary, MyGenome Sdn. Bhd., received MS ISO 15189:2022 accreditation for Whole Genome Sequencing (WGS).
- MS ISO 15189:2022 is an internationally recognized clinical standard for quality and competence in medical laboratories.
- The accreditation confirms MyGenome's genomic data meets accuracy, reproducibility, and reliability benchmarks for clinical use.
- MyGenome joins a limited number of Southeast Asian laboratories delivering WGS under these international standards.
- This milestone broadens Alps' addressable market to include government-linked healthcare programs and institutional clients.
- The accreditation validates MyGenome's clinical infrastructure and enhances the global credibility of its genomic data.
Price Impact
More from ALPS